Application of Bayesian approaches in drug development: starting a virtuous cycle

The pharmaceutical industry and its global regulators have routinely used frequentist statistical methods, such as null hypothesis significance testing and p values, for evaluation and approval of new treatments. The clinical drug development process, however, with its accumulation of data over time...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruberg, Stephen J., Beckers, Francois, Hemmings, Rob, Honig, Peter, Irony, Telba, LaVange, Lisa, Lieberman, Grazyna, Mayne, James, Moscicki, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931171/
https://www.ncbi.nlm.nih.gov/pubmed/36792750
http://dx.doi.org/10.1038/s41573-023-00638-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931171/
https://www.ncbi.nlm.nih.gov/pubmed/36792750
http://dx.doi.org/10.1038/s41573-023-00638-0

Ejemplares similares